NasdaqGM - Nasdaq Real Time Price USD
Cartesian Therapeutics, Inc. (RNAC)
10.77
-0.08
(-0.74%)
At close: June 10 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 771.43k | 771.43k | 3.48M | 337.5k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 5M | 5M | 20M | 1.6M |
| Year Ago Sales | 33.45M | 387k | 38.91M | 3.48M |
| Sales Growth (year/est) | -97.69% | 99.34% | -91.07% | -90.29% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.55 | -0.83 | -0.71 |
| EPS Actual | 0.64 | -0.42 | -0.59 | -0.65 |
| Difference | 0.73 | 0.13 | 0.23 | 0.06 |
| Surprise % | 770.53% | 23.09% | 28.13% | 7.89% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RNAC | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 5/8/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/9/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Reiterates | Needham: Buy to Buy | 3/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/28/2025 |
Related Tickers
KYTX Kyverna Therapeutics, Inc.
3.6000
+4.35%
CGEM Cullinan Therapeutics, Inc.
9.03
+3.08%
TRVI Trevi Therapeutics, Inc.
6.51
+1.56%
CGON CG Oncology, Inc.
27.48
+1.78%
KROS Keros Therapeutics, Inc.
13.75
-2.41%
JANX Janux Therapeutics, Inc.
26.24
+1.16%
COGT Cogent Biosciences, Inc.
7.42
+7.54%
TCRX TScan Therapeutics, Inc.
1.6900
-4.52%
LXEO Lexeo Therapeutics, Inc.
4.6100
+5.25%
DSGN Design Therapeutics, Inc.
4.0100
+2.56%